Valuation: Abbott Laboratories

Capitalization 154B 133B 121B 115B 212B 14,841B 216B 1,445B 564B 7,021B 578B 565B 24,506B P/E ratio 2026 *
22.2x
P/E ratio 2027 * 19x
Enterprise value 166B 143B 131B 124B 229B 15,980B 233B 1,556B 608B 7,560B 622B 609B 26,388B EV / Sales 2026 *
3.3x
EV / Sales 2027 * 2.97x
Free-Float
86.73%
Yield 2026 *
2.8%
Yield 2027 * 2.98%
1 day-0.66%
1 week+3.31%
Current month-3.39%
1 month-5.40%
3 months-23.92%
6 months-31.54%
Current year-29.99%
1 week 84.13
Extreme 84.13
89.34
1 month 81.97
Extreme 81.97
94.79
Current year 81.97
Extreme 81.97
129.46
1 year 81.97
Extreme 81.97
139.06
3 years 81.97
Extreme 81.97
141.23
5 years 81.97
Extreme 81.97
142.6
10 years 36.76
Extreme 36.76
142.6
Manager TitleAgeSince
Chief Executive Officer 52 2020-03-30
Director of Finance/CFO 53 2023-08-31
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 2011-12-08
Director/Board Member 67 2011-12-08
Director/Board Member 71 2017-02-15
Change 5d. change 1-year change 3-years change Capi.($)
-0.64%+3.31%-34.08%-18.97% 154B
-0.51%+0.96%-7.94%-13.17% 100B
+0.30%-3.97%+48.99%+61.58% 55.82B
-0.23%+1.33%-9.19%+53.60% 51.51B
-0.20%+1.37%-15.42%-41.66% 40.49B
+3.94%-3.19% - - 30.65B
+0.62%+23.80%-15.68%-39.99% 27.57B
-0.45%+19.59%-13.44%+12.28% 21.76B
+2.75%+5.04%+50.91%-10.14% 21.58B
+1.24%+1.56%-10.95%+6.01% 21.18B
Average +0.68%+4.40%-0.75%+1.06% 52.48B
Weighted average by Cap. +0.11%+3.70%-8.63%-1.33%

Financials

2026 *2027 *
Net sales 50.3B 43.41B 39.7B 37.52B 69.34B 4,849B 70.57B 472B 184B 2,294B 189B 185B 8,007B 54.82B 47.31B 43.26B 40.9B 75.58B 5,285B 76.92B 514B 201B 2,500B 206B 201B 8,727B
Net income 7.02B 6.06B 5.54B 5.24B 9.68B 677B 9.85B 65.87B 25.73B 320B 26.34B 25.78B 1,117B 8.17B 7.05B 6.45B 6.09B 11.26B 787B 11.46B 76.65B 29.94B 373B 30.65B 30B 1,300B
Net Debt 11.82B 10.2B 9.33B 8.82B 16.29B 1,139B 16.58B 111B 43.32B 539B 44.35B 43.41B 1,881B 8.71B 7.52B 6.88B 6.5B 12.01B 840B 12.23B 81.78B 31.95B 397B 32.7B 32.01B 1,387B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change Volume
26-05-21 87.76 $ -0.71% 5,176,517
26-05-20 88.38 $ -0.50% 7,834,359
26-05-19 88.82 $ +1.04% 11,693,547
26-05-18 87.91 $ +4.07% 12,346,980
26-05-15 84.47 $ -0.51% 13,208,556
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
88.38USD
Average target price
118.64USD
Spread / Average Target
+34.24%

Quarterly revenue - Rate of surprise